Search results
Results From The WOW.Com Content Network
UNAIDS Headquarters building in Geneva, Switzerland. The Joint United Nations Programme on HIV and AIDS (UNAIDS; French: Programme commun des Nations Unies sur le VIH/sida, ONUSIDA) is the main advocate for accelerated, comprehensive and coordinated global action on the HIV/AIDS pandemic.
UNAIDS is a joint venture of the United Nations and has a target of putting an end to the disease as a public health threat by 2030. (Reporting by Sriparna Roy in Bengaluru; Editing by Shilpi ...
UNAIDS, the United Nations agency leading the fight against HIV, said on Wednesday the waiver included HIV treatment, and that it would lobby for other HIV services to be included too, including ...
The Joint United Nations Programme on HIV/AIDS (UNAIDS) became operational in 1996, and it took over the planning and promotion of World AIDS Day. [8] Rather than focus on a single day, UNAIDS created the World AIDS Campaign in 1997 to focus on year-round communications, prevention and education.
Winifred Byanyima (born 13 January 1959 [citation needed]), is a Ugandan aeronautical engineer, politician, human rights activist, feminist and diplomat.She is the executive director of UNAIDS, effective November 2019.
In December 2014, PEPFAR announced a program PEPFAR 3.0 focusing on Sustainable Control of the AIDS epidemic. This program was designed to address the UNAIDS "90-90-90" global goal: 90 percent of people with HIV diagnosed, 90 percent of them on ART and 90 percent of them virally suppressed by the year 2020. [13]
Dr Luiz Loures was the Deputy Executive Director, Joint United Nations Programme on HIV/AIDS (UNAIDS). He was appointed [1] to this position at the level of Assistant Secretary-General [2] [circular reference] of the United Nations by the United Nations Secretary-General Ban Ki-moon on 14 December 2012. [3]
The UNAIDS 2021 data estimates that about 58% of the HIV 4000 incidences per day are in Sub-Saharan Africa. [41] Presently, Southern Africa is the hardest hit region, with adult prevalence rates exceeding 20% in most countries in the region, and 30% in Eswatini and Botswana .